Our CAR T-cell Therapy Physician Team

Explore Related Services

Clinical Trials of New Cellular Therapies

Our physicians work to bring the latest breakthroughs in cellular therapy treatments quickly to their patients’ bedsides. Several new cellular therapies are now being tested through clinical trials for blood cancers and solid tumors.

Convenient Locations for Cancer Care

Request an Appointment for CAR T-Cell Therapy

The secure form to request an appointment with a UChicago Medicine CAR T-cell therapy expert will enable us to assist you as efficiently as possible. A representative will contact you within one to two business days to help you schedule an appointment.

You can also make an appointment with our providers by:

– Scheduling a virtual video visit to see a provider from the comfort of your home

– Requesting an online second opinion from our specialists 

To speak to someone directly, please call 1-844-482-7823. If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.

 

For Referring Physicians

To refer a patient for CAR T-cell therapy, please call 1-844-482-7832.

Privacy Policy

* Required Field

CAR T-Cell Therapy Articles

Therese McGee received CAR T-cell therapy for cancer and is now in remission
‘We’re gonna get this’: How CAR T-cell therapy helped a 72-year-old lymphoma patient become cancer-free
Rendering of new UChicago Medicine Comprehensive Cancer Center hospital
State approves UChicago Medicine’s $815M plan to build city's first freestanding cancer care and research facility
Michael R. Bishop, MD, presents the David Jonas Memorial Award to Hans Schreiber, MD, PhD.
Hans Schreiber receives inaugural Jonas Memorial Award for contributions to cellular immunotherapy
CAR T-cell therapy patient Andrew Parker
CAR T-cell therapy recipient surpasses 5-year cancer-free mark
Cindy and Scott McIntyre. Scott is a CAR T-cell therapy patient
Six years after CAR T-cell therapy for lymphoma, patient still cancer-free
car t cell therapy
CAR T-cell therapy found equivalent to standard of care as second-line treatment for aggressive non-Hodgkin lymphoma
two staff members in Advanced Cellular Therapeutics Facility (ACTF)
New facility brings the most advanced cellular therapies to patients
CAR-T therapy patient Scott McIntyre with Michael Bishop, MD
CAR T-cell update: therapy improves outcomes for patients with B-cell lymphoma
illustration of immunotherapy heroes attacking cancer cells
Immunotherapy: Using the body's immune system to fight cancer